Drug Database
CS

CSF-G

✓ Approved

Dong-A ST · CSF3R · Recombinant Proteins

What is CSF-G?

CSF-G is a recombinant proteins developed by Dong-A ST. It is approved for therapeutic indications via injectable (others) or subcutaneous injection.

Drug Profile

CompanyDong-A ST
Drug ClassRecombinant Proteins
Molecular TargetCSF3R
RouteInjectable (Others), Subcutaneous Injection
StatusApproved

Mechanism of Action

Molecular Targets

CSF-G acts on 1 molecular target:

CSF3Rcolony stimulating factor 3 receptor (CD114, GCSFR)
Want deeper analysis?Noah AI can explain complex mechanisms and compare to similar drugs.

Therapeutic Indications

CSF-G is developed for 1 unique indication across 1 therapeutic area.

Therapeutic AreaConditionPhase
Blood and lymphatic system disordersNeutropenia✓ Approved

Related Research Articles

PubMedAJNR. American journal of neuroradiology2026-08-08

Dorsal spinal CSF leaks in patients with spontaneous intracranial hypotension: a radiologic-anatomic study.

Schievink Wouter I WI, Maya Marcel M MM, Giang Kim T KT, Taché Rachelle B RB et al.

Spontaneous spinal CSF leaks cause spontaneous intracranial hypotension (SIH) and several types have been identified. One rare type is the dorsal CSF leak and performing myelography in the supine or lateral decubitus position allows precise characterization of these leaks. The purpose of the current study is to describe the characteristics of spontaneous dorsal spinal CSF leaks. Using a prospectively maintained registry, we reviewed the medical records and radiographic studies of a group of consecutive patients with SIH and dorsal spinal CSF leaks who 1) underwent digital subtraction myelography (DSM) in the lateral decubitus or supine position and 2) underwent surgery to repair the dorsal CSF leak at a quaternary referral center for SIH. The mean age of the 16 study patients (eight female and eight male) was 34.3 years (range, 12 to 75 years) at the time of SIH symptom onset. Two different variants of spontaneous dorsal CSF leak could be identified. Of the 16 patients, 12 patients (75%) had a simple linear dural tear and four patients (25%) had one or more pseudo-meningoceles. An extradural CSF collection, usually extensive spanning many spinal levels, was seen in all patients with a linear dural tear. Half of the dorsal CSF leaks were located in the mid-thoracic spine between T5 and T8. Findings on DSM were concordant with intra-operative findings in all patients. Spontaneous dorsal spinal CSF leaks affect men and women about equally, across a wide age range, with a predilection for the mid-thoracic spine. Two variants of spontaneous dorsal dural tears can be identified, simple linear dural tears and pseudo-meningoceles. Spontaneous dorsal spinal CSF leaks have unique features that distinguishes them from other spontaneous spinal CSF leaks.

PubMedOpen forum infectious diseases2026-08-08

Minimally Invasive Tissue Sampling for Postmortem Diagnosis of Tuberculous Meningitis in Zambian Adults.

Siddiqi Omar K OK, Birbeck Gretchen L GL, Kabwe Caroline C, Moonga Gift G et al.

The true burden of tuberculous meningitis (TBM), particularly in low and middle-income countries, is unknown due to imperfect diagnostics. Complete diagnostic autopsy (CDA) to confirm TBM in deceased meningitis patients is uncommon. Minimally invasive tissue sampling (MITS) has been shown to be a viable alternative to CDA to establish infectious etiologies of meningitis. We used MITS to determine the burden of TBM among deceased adult Zambians who presented with meningitis. We performed a prospective cohort study of Zambian adults who presented with symptoms suggestive of TBM, recording whether they had a complete cerebrospinal fluid (CSF) diagnostic assessments during their admission. We followed patients for the outcome of discharge or death. Among those who died, after obtaining consent from the family, we performed MITS, collecting CSF, brain, lung, and liver tissue looking for evidence of Mycobacterium tuberculosis infection. We completed MITS on 50 deceased Zambian adults who presented with meningitis symptoms. Twenty-two cases had a complete antemortem CSF evaluation. Among these cases, 4/22 (18%) were diagnosed with TBM before death and an additional 2/22 (9%) were diagnosed with TBM via MITS after death. Twenty-eight deaths occurred in patients with an incomplete or no CSF evaluation. Among these cases, 4/28 (14%) were diagnosed with TBM via MITS. MITS can confirm the diagnosis of TBM in deceased meningitis patients. It can be a valuable tool in meningitis surveillance to establish an infectious etiology.

PubMedIDCases2026-08-08

Healthcare-associated post-neurosurgical meningitis caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in an Infant: A case report.

Mizuno Shinsuke S, Koyama Junji J, Kurosawa Hiroshi H, Imuta Naoko N et al.

Healthcare-associated meningitis caused by extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae is a well-recognized condition after neurosurgical procedures in adults; however, it remains uncommon in children, particularly when detailed microbiological characterization is available. Here we report a case of ESBL-producing K. pneumoniae meningitis with hypervirulent features following neurosurgical intervention in an infant. A previously healthy male infant developed fever and seizures on day of life 58, 2 days after external ventricular drain (EVD) placement and tumor resection. Cerebrospinal fluid (CSF) analysis revealed pleocytosis and gram-negative bacilli. Intravenous meropenem was initiated, and EVD was removed. Cultures from CSF and the catheter yielded ESBL-producing K. pneumoniae (ST37) harboring blaCTX-M-15, blaSHV-11, and blaTEM-1. The isolate demonstrated hypermucoviscosity and carried virulence-associated genes. CSF sterilization was achieved within 5 days; however, the clinical course was complicated by cranial nerve deficits. The patient completed 8 weeks of therapy and was discharged with persistent neurological sequelae. The findings from this case suggest that ESBL-producing Gram-negative bacilli should be considered for infants with post-neurosurgical meningitis when risk factors such as EVD placement, CSF leakage, and healthcare exposure are present. Prompt source control and empiric antimicrobial therapy guided by local resistance epidemiology are critical. Although resistance and virulence-associated traits were identified in our case, their contribution to the neurological sequelae remains uncertain.

PubMedClinical lymphoma, myeloma & leukemia2026-08-08

Clonal Hematopoiesis in Newly Diagnosed Multiple Myeloma: Associations With Neutropenia, Supportive Care Burden, and Survival.

Yigitbasi Ahmet A, Puyan Fulya Oz FO, Kirkizlar Hakki Onur HO, Kirkizlar Tugcan Alp TA et al.

Clonal hematopoiesis (CH) is increasingly recognized as a clinically relevant host factor in newly diagnosed multiple myeloma (NDMM), with potential implications for frailty, treatment tolerance, supportive care burden, and overall survival (OS). We retrospectively analyzed 181 patients with NDMM whose diagnostic bone marrow specimens were evaluated using targeted next-generation sequencing (NGS). Clinical data were abstracted from electronic records and paper charts. Associations between CH and treatment-related cytopenias, supportive care requirements, recurrent infections, and OS were evaluated using logistic regression and Cox proportional hazards models. The mean age was 69 years 58% were male, first-line induction consisted mainly VCd (n = 109, 60.2%) or VRd (n = 54, 29.8%) and CH was identified in 77 patients (42.6%). CH was associated with neutropenia at diagnosis (P = .023), during first-line treatment (P < .001), and during maintenance therapy (P = .009), as well as erythrocyte transfusion support (P < .001), recurrent infections (P = .027), and granulocyte colony-stimulating factor (G-CSF) use (P < .001). In multivariable analyses, CH was independently associated with neutropenia during first-line treatment (odds ratio [OR]: 4.4, P < .001) and maintenance therapy (OR: 6.7, P = .003), recurrent infections (OR: 2.5, P = .041), erythrocyte transfusion support (OR: 3.8, P = .006), and granulocyte colony-stimulating factor use (OR: 2.2, P = .026). CH was also independently associated with inferior OS (hazard ratio [HR]: 1.7, P = .036), with a similar adverse association among patients harboring at least 2 CH mutations (HR: 1.9, P = .032). CH was associated with baseline and treatment-related cytopenias, greater supportive care requirements, recurrent infections, and inferior OS, supporting its potential clinical relevance for cytopenia risk stratification and supportive-care planning during contemporary multiple myeloma therapy.

PubMedThe British journal of general practice : the journal of the Royal College of General Practitioners2026-08-08

Why Primary Care Clinicians use Advice and Guidance: A qualitative study.

Faux-Nightingale Alice A, Harrison Rosie R, Burton Claire C, Bajpai Ram R et al.

Background Where available, Advice and Guidance (A&G) can enable primary care clinicians to seek specialist input, supporting decision making and avoiding unnecessary referrals. The use of A&G has significantly expanded, accelerated by COVID19 and contractual changes. While A&G is intended to streamline elective care, concerns persist regarding workload shift, variable responsiveness, and system usability. Despite growing policy emphasis, little is known about why clinicians choose to use A&G. Aim Explore the current use of A&G within primary care, focusing on decision making processes which underpin PCCs' (primary care clinicians') decision to use A&G. Design and Setting Qualitative study set in English Primary Care Method Twenty semi structured video interviews were conducted with primary care clinicians purposively sampled for maximum variation. Data were analysed using reflexive thematic analysis within an interpretive description framework, with themes developed collaboratively and refined through discussion with researchers and PPIE contributors. Ethical approval was obtained (REC 333799). Results Four overarching themes encapsulate clinicians' decisions to use A&G: clinical presentation (acuity and complexity), navigating healthcare pathways, previous experiences of A&G, and using A&G to validate clinical decision making. Barriers included delayed responses and uncertainty about inequitable workload distribution. These factors shape how effectively A&G could be integrated into routine practice. Conclusion Primary care clinicians use A&G to support patient care and aid decision-making, but its effectiveness depends on timely, clinically helpful responses. Ensuring responses remain appropriate to primary care remit and capacity will be essential if A&G becomes the main route into elective care.

PubMedJournal of advanced research2026-08-08

Valine modulates Alzheimer's disease risk in APOE ε4 carriers: evidence from two cohorts.

Yang Ze-Lin ZL, Zhang Can C, Tang Shi S, Zhang Xin-Yu XY et al.

The apolipoprotein E ε4 (APOE ε4) allele confers the greatest genetic risk for sporadic Alzheimer's disease (AD). To identify APOE ε4-associated metabolic factors related to AD risk and to provide preliminary insights into their biological and nutritional context. We leveraged multi-omics analyses across two independent cohorts to characterize biomarkers associated with AD. The effects of metabolite × APOE ε4 interactions were tested on incident AD and the ε4-specific metabolic signatures were pinpointed. Multimodal analyses were used to test the underlying mechanisms, including neuroimaging, cerebrospinal fluid (CSF), and PET biomarkers within the A/T/N framework, as well as plasma proteomics combined with bioinformatics enrichment analyses. Across both cohorts, valine emerged as the only metabolite associated with a reduced risk of incident AD specifically among APOE ε4 carriers (P < 0.005). Significant interaction effects between valine and APOE ε4 were detected in both cohorts (P for meta-analyses < 0.005). Higher levels of valine were associated with greater total white matter and posterior cingulate cortex volumes, as well as with lower levels of CSF tau proteins. Higher valine levels also predicted a slower decline in FDG-PET metabolism. No association was found between valine and Aβ. Mediation analyses of plasma proteomic data suggested statistically significant mediation effects involving GFAP, NEFL, and APOE (P < 2 × 10-16). Valine is a metabolite associated with lower AD risk in APOE ε4 carriers, with potential associations with tau pathology, neurodegeneration, and neuroinflammation-related processes. As this was an observational study, causality cannot be inferred.

+9996 more articles available with a free account

Sign up free to view all articles →

Ask about CSF-G